diazoxide and hc 030031

diazoxide has been researched along with hc 030031 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babes, A; Engel, MA; Filipovic, M; Fischer, MJ; Flonta, ML; Reeh, PW	1

Other Studies

1 other study(ies) available for diazoxide and hc 030031

Article	Year
The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel. European journal of pharmacology, 2013, Mar-15, Volume: 704, Issue:1-3 Topics: Acetanilides; Animals; Calcium; Calcium Channels; Cells, Cultured; Cysteine; Diazoxide; Ganglia, Spinal; Glyburide; HEK293 Cells; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Purines; Recombinant Proteins; Sensory Receptor Cells; Transient Receptor Potential Channels; TRPA1 Cation Channel	2013

Article

Year

The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel.

European journal of pharmacology, 2013, Mar-15, Volume: 704, Issue:1-3

Topics: Acetanilides; Animals; Calcium; Calcium Channels; Cells, Cultured; Cysteine; Diazoxide; Ganglia, Spinal; Glyburide; HEK293 Cells; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Purines; Recombinant Proteins; Sensory Receptor Cells; Transient Receptor Potential Channels; TRPA1 Cation Channel

2013